Higher rebates for brand-name drugs result in lower costs for Medicaid compared to Medicare Part D.

Bibliographic Details
Corporate Author:	United States. Department of Health and Human Services. Office of Inspector General (Author)
Format:	Government Document eBook
Language:	English
Published:	[Washington, D.C.] : Department of Health and Human Services, Office of Inspector General, 2011.
Subjects:	Medicare. Medicaid. Pharmaceutical services insurance > United States > Auditing. Drugs > Prices > United States. Brand name products > Prices > United States.
Online Access:	https://purl.fdlp.gov/GPO/gpo68404

Available Online